Armata Pharmaceuticals (ARMP) Accumulated Depreciation & Amortization (2016 - 2026)
Quarterly results put Accumulated Depreciation & Amortization at $14.5 million for Q1 2026, up 7.2% from a year ago — trailing twelve months through Mar 2026 was $14.5 million (up 7.2% YoY), and the annual figure for FY2025 was $14.0 million, up 6.8%.
Armata Pharmaceuticals has reported Accumulated Depreciation & Amortization over the past 14 years, most recently at $14.5 million for Q1 2026.
- Accumulated Depreciation & Amortization reached $14.5 million in Q1 2026 per ARMP's latest filing, up from $14.0 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $14.5 million in Q1 2026 and bottomed at $10.4 million in Q1 2022.
- Median Accumulated Depreciation & Amortization over the past 5 years was $12.1 million (2024), compared with a mean of $12.4 million.
- The largest annual shift saw Accumulated Depreciation & Amortization increased 11.93% in 2022 before it rose 6.47% in 2023.
- Over 5 years, Accumulated Depreciation & Amortization stood at $11.1 million in 2022, then grew by 6.47% to $11.8 million in 2023, then grew by 11.21% to $13.1 million in 2024, then rose by 6.8% to $14.0 million in 2025, then rose by 3.25% to $14.5 million in 2026.
- Business Quant data shows Accumulated Depreciation & Amortization for ARMP at $14.5 million in Q1 2026, $14.0 million in Q4 2025, and $14.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.50 Mn |
| Mar 31, 2026 | 14.50 Mn |
| Dec 31, 2025 | 14.04 Mn |
| Dec 31, 2025 | 14.04 Mn |
| Sep 30, 2025 | 14.26 Mn |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 13.89 Mn |
| Jun 30, 2025 | 13.89 Mn |
| Mar 31, 2025 | 13.52 Mn |
| Mar 31, 2025 | 13.52 Mn |
| Dec 31, 2024 | 13.15 Mn |
| Dec 31, 2024 | 13.15 Mn |
| Sep 30, 2024 | 12.77 Mn |
| Sep 30, 2024 | 12.77 Mn |
| Jun 30, 2024 | 12.45 Mn |
| Jun 30, 2024 | 12.45 Mn |
| Mar 31, 2024 | 12.14 Mn |
| Mar 31, 2024 | 12.14 Mn |
| Dec 31, 2023 | 11.82 Mn |
| Dec 31, 2023 | 11.82 Mn |
| Sep 30, 2023 | 11.77 Mn |
| Sep 30, 2023 | 11.77 Mn |
| Jun 30, 2023 | 11.56 Mn |
| Jun 30, 2023 | 11.56 Mn |
| Mar 31, 2023 | 11.33 Mn |
| Mar 31, 2023 | 11.33 Mn |
| Dec 31, 2022 | 11.10 Mn |
| Dec 31, 2022 | 11.10 Mn |
| Sep 30, 2022 | 10.87 Mn |
| Sep 30, 2022 | 10.87 Mn |
| Jun 30, 2022 | 10.65 Mn |
| Jun 30, 2022 | 10.65 Mn |
| Mar 31, 2022 | 10.45 Mn |
| Mar 31, 2022 | 10.45 Mn |
| Dec 31, 2021 | 10.23 Mn |
| Dec 31, 2021 | 10.23 Mn |
| Sep 30, 2021 | 9.95 Mn |
| Sep 30, 2021 | 9.95 Mn |
| Jun 30, 2021 | 9.63 Mn |
| Jun 30, 2021 | 9.63 Mn |
| Mar 31, 2021 | 9.34 Mn |
| Mar 31, 2021 | 9.34 Mn |
| Dec 31, 2020 | 9.06 Mn |
| Dec 31, 2020 | 9.06 Mn |
| Sep 30, 2020 | 8.78 Mn |
| Sep 30, 2020 | 8.78 Mn |
| Jun 30, 2020 | 8.72 Mn |
| Jun 30, 2020 | 8.72 Mn |
| Mar 31, 2020 | 8.45 Mn |
| Mar 31, 2020 | 8.45 Mn |
| Dec 31, 2019 | 8.16 Mn |
| Dec 31, 2019 | 8.16 Mn |
| Sep 30, 2019 | 9.09 Mn |
| Sep 30, 2019 | 9.09 Mn |
| Jun 30, 2019 | 10.26 Mn |
| Jun 30, 2019 | 10.26 Mn |
| Dec 31, 2018 | 7.89 Mn |
| Dec 31, 2018 | 7.89 Mn |
| Dec 31, 2017 | 1.17 Mn |
| Dec 31, 2017 | 1.17 Mn |
| Dec 31, 2016 | 932,000.00 |
| Dec 31, 2016 | 932,000.00 |